Xtx Topco LTD Igm Biosciences, Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 11,941 shares of IGMS stock, worth $83,706. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,941

Holding current value

$83,706

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$8.68 - $17.36 $103,647 - $207,295	11,941 New	11,941 $115,000
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $76,223 - $121,774	11,445 New	11,445 $95,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.5M

Call Options Held

11.1K

Put Options Held

5.1K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$28.7 Million
0.5% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.89M
Shares

$27.3 Million
0.0% of portfolio
Artal Group S.A. Luxembourg, N4

3.08M
Shares

$21.6 Million
1.6% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$21.5 Million
1.17% of portfolio
Goldman Sachs Group Inc New York, NY

1.28M
Shares

$8.96 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $203M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account